Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
5 things to know before the stock market opens Tuesday
Tags Investment strategy Investing Politics
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Markets Business News Europe News
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Business Pharmaceuticals US: News
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags Health care industry Technology Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Business Pharmaceuticals Breaking news
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Merck & Co Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Abbvie Inc Business Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Healthy Returns Eli Lilly and Co Health care industry
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Business Pharmaceuticals Breaking news
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Altimmune Inc Healthy Returns Viking Therapeutics Inc
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Business News Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags AstraZeneca PLC Health & Science Bristol/Myers Squibb Co
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Markets Business News Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Novo Nordisk A/S Pfizer Inc Merck & Co Inc
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Healthy Returns Eli Lilly and Co Health care industry
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Pharmaceuticals Business Health & Science
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Novo Nordisk A/S Markets Investment strategy
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Sanofi SA Business Pharmaceuticals
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Breaking News: Politics JPMorgan Chase & Co Morgan Stanley
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Novo Nordisk A/S Interest Rates Elections
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags U/S/ Markets Biotechnology Investing
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Health & Science Altimmune Inc Gilead Sciences Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Oracle Corp
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.